Aurobindo Pharma Initiates Rs 800 Crore Buyback
Aurobindo Pharma Ltd has announced a Rs 800 crore buyback offer starting April 23 and ending April 29. The buyback involves up to 54,23,728 equity shares at Rs 1,475 per share. The move aims to reward shareholders and enhance financial ratios without altering the company's management structure.
- Country:
- India
Aurobindo Pharma Ltd revealed plans for an Rs 800 crore share buyback, with the tender opening on April 23 and concluding on April 29, as stated in their latest regulatory filing.
The buyback will cover up to 54,23,728 shares priced at Rs 1,475 each, aiming to reward shareholders while also improving financial metrics over time.
This initiative, endorsed by the board earlier in April, does not alter the company's managerial structure but is poised to boost key financial indicators such as earnings per share and return on assets.
ALSO READ
-
Aurobindo Pharma Receives USFDA Nod for Glycerol Phenylbutyrate Launch
-
Wipro Unveils Ambitious $1.6 Billion Share Buyback Plan
-
Wipro Embarks on Its Largest Share Buyback Offer of Rs 15,000 Crore
-
Wipro Announces Landmark Rs 15,000 Crore Share Buyback
-
Wipro Navigates Economic Challenges with Strategic Share Buyback
Google News